Advertisement

Is Chinese Medicine Injection Applicable for Treating Acute Lung Injury and Acute Respiratory Distress Syndrome? A Systematic Review and Meta-analysis of Randomized Controlled Trials

  • Yuan-bin Chen
  • Qiao Liu
  • Han Xie
  • Shuo-miao Yin
  • Lei Wu
  • Xu-hua Yu
  • Long Fan
  • Lin LinEmail author
Evidence-Based Integrative Medicine
  • 3 Downloads

Abstract

Objective

To assess the efficacy and safety of Chinese medicine injection (CMI) for treating acute lung injury/acute respiratory distress syndrome (ALI/ARDS).

Methods

Randomized controlled trials (RCTs) were identified by searching 3 English databases and 4 Chinese databases from their inceptions until February 2019. The Cochrane Handbook was used to evaluate risk of bias in the included studies. Data analysis was conducted using RevMan 5.3.3 software.

Results

A total of 19 eligible RCTs involving 1,334 participants was included in this systematic review and meta-analysis. The main meta-analysis showed that CMI combined with conventional therapy (CT) was more effective than CT alone in reducing the acute physiology and chronic health evaluation (APACHE) H score [mean difference (MD): −1.74 points, 95% confidence interval (CI): −2.77 to −0.71, I2=0] and increasing the total effective rate [relative risk (RR): 1.35, 95% CI: 1.17 to 1.56, I2=37%]. Compared with CT, CMI combined with CT showed improvements in the arterial partial pressure of oxygen (PaO2, MD: 9.25 mm Hg, 95% CI: 0.87 to 17.63, I2=98%) and oxygenation index [arterial partial pressure of oxygen (PaO2)/fraction of inspired oxygen (FiO2), MD: 50.75 mm Hg, 95% CI: 35.18 to 66.31, I2=94%]. CMI plus CT was superior to CT in reducing the systemic inflammatory response syndrome (SIRS) score (MD: −0.84 points, 95% CI: −1.26 to −0.42, I2=65%), length of hospital stay (MD: −4.22 days, 95% CI: −6.49 to −1.95, I2=92%), and duration of mechanical ventilation (MD: −2.94 days, 95% CI: −4.68 to −1.21, I2=89%). Only 1 study reported adverse events.

Conclusions

CMI as an adjuvant therapy showed great potential benefits for the treatment of ALI/ARDS. However, we could not make a definite conclusion due to low quality of included studies and uncertain security. Future studies should focus on improving research design, especially in blindness and placebo. The reporting of adverse events was also needed.

Keywords

Chinese medicine injection acute lung injury acute respiratory distress syndrome systematic review 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Notes

Acknowledgments

The authors thank Bo Li and evidence based clinical club for their help with methodological guidance.

Author Contributions

Lin L initiated and supervised the study. Chen YB and Liu Q conceived the project, analyzed the data and drafted the manuscript. Xie H and Yin SM searched the electronic databases and screened and extracted the studies. Wu L and Yu XH evaluated the risk of bias, and interpreted the evidence from a clinical perspective. Fan L participated in the revision of the manuscript. All authors read and approved the final manuscript.

Conflict of Interest

The authors declare no conflicts of interest, and are responsible for the content and writing of the paper.

Supplementary material

11655_2019_3078_MOESM1_ESM.docx (48 kb)
Supplementary material, approximately 48 KB.
11655_2019_3078_MOESM2_ESM.docx (26 kb)
Supplementary material, approximately 28 KB.
11655_2019_3078_MOESM3_ESM.docx (27 kb)
Supplementary material, approximately 28 KB/MB.
11655_2019_3078_MOESM4_ESM.jpg (150 kb)
Supplementary material, approximately 154 KB.
11655_2019_3078_MOESM5_ESM.jpg (73 kb)
Supplementary material, approximately 74 KB.
11655_2019_3078_MOESM6_ESM.jpg (244 kb)
Supplementary material, approximately 249 KB.
11655_2019_3078_MOESM7_ESM.jpg (121 kb)
Supplementary material, approximately 123 KB.
11655_2019_3078_MOESM8_ESM.jpg (190 kb)
Supplementary material, approximately 194 KB.
11655_2019_3078_MOESM9_ESM.jpg (125 kb)
Supplementary material, approximately 128 KB.

References

  1. 1.
    Bernard GR, Artigas A, Brigham KL, et al. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 1994;149:818–824.PubMedPubMedCentralGoogle Scholar
  2. 2.
    The ARDS Definition Task Force. Acute respiratory distress syndrome, the Berlin definition. JAMA 2012;307:2526–2533.Google Scholar
  3. 3.
    Rubenfeld GD, Caldwell E, Peabody E, et al. Incidence and outcomes of acute lung injury. N Engl J Med 2005;353:1685–1693.PubMedCrossRefPubMedCentralGoogle Scholar
  4. 4.
    Fan E, Brodie D, Slutsky AS. Acute respiratory distress syndrome: advances in diagnosis and treatment. JAMA 2018;319:698–710.PubMedCrossRefPubMedCentralGoogle Scholar
  5. 5.
    Johnson ER, Matthay MA. Acute lung injury: epidemiology, pathogenesis, and treatment. J Aerosol Med Pulm Drug Deliv 2010;23:243–252.PubMedPubMedCentralCrossRefGoogle Scholar
  6. 6.
    Matthay MA, Zimmerman GA, Esmon C, et al. Future research directions in acute lung injury: summary of a National Heart, Lung, and Blood Institute working group. Am J Respir Crit Care Med 2003;167:1027–1035.PubMedCrossRefPubMedCentralGoogle Scholar
  7. 7.
    Fan E, Del SL, Goligher EC, et al. An official American Thoracic Society/European Society of Intensive Care Medicine/Society of Critical Care Medicine clinical practice guideline: mechanical ventilation in adult patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 2017;195:1253–1263.PubMedCrossRefPubMedCentralGoogle Scholar
  8. 8.
    Matthay MA, Zimmerman GA. Acute lung injury and the acute respiratory distress syndrome: four decades of inquiry into pathogenesis and rational management. Am J Respir Cell Mol Biol 2005;33:319–327.PubMedPubMedCentralCrossRefGoogle Scholar
  9. 9.
    Levy BD, Clish CB, Schmidt B, et al. Lipid mediator class switching during acute inflammation: signals in resolution. Nat Immunol 2001;2:612–619.CrossRefGoogle Scholar
  10. 10.
    Calfee CS, Matthay MA. Nonventilatory treatments for acute lung injury and ARDS. Chest 2007;131:913–920.PubMedPubMedCentralCrossRefGoogle Scholar
  11. 11.
    Li YK, Zhang JY. The improvement and enhancement of traditional Chinese medicine injections. China J Chin Mater Med (Chin) 2011;36:1905–1909.Google Scholar
  12. 12.
    Xue LX, Chen JR, Tao YJ, et al. Effects of Xuebijing on nitric oxide and VEGF-A in exhaled breath condensate of patients with ALI/ARDS. Chin J Integr Tradit West Med (Chin) 2013;33:766–799.Google Scholar
  13. 13.
    Yang SX, Zhao YL, Zeng JY. Recent application of Tanreqing Injection in acute lung injury. Intern Med (Chin) 2009;4:918–921.Google Scholar
  14. 14.
    Higgins JPT, Green S. Cochrane handbook for systematic reviews of interventions version 5.3.3 (updated 2016). The Cochrane Collaboration.Google Scholar
  15. 15.
    Zhang H. The clinical study of Tanreqing Injection in acute lung injury. Med People (Chin) 2014;27:70.Google Scholar
  16. 16.
    You WL. The clinical randomized-controlled study of Tanreqing Injection in acute lung injury. J Clin Pulm Med (Chin) 2012;17:1987–1988.Google Scholar
  17. 17.
    Yang SX, Zhao YL, Zeng JY, et al. Clinical observation of Tanreqing Injection on acute lung injury patients. Guangxi Med J (Chin) 2010;32:144–147.Google Scholar
  18. 18.
    Zhang HX, Bao N, He YS. Application of Tanreqing Injection in acute lung injury. J Emerg Tradit Chin Med (Chin) 2013;22:639–640.Google Scholar
  19. 19.
    Guo LM, Guo S, Ma HH. Effect of Tanreqing Injection on levels of inflammatory mediators in patients with acute lung injury. Chin J Integr Tradit West Med Intensive Crit Care (Chin) 2018;25:242–245.Google Scholar
  20. 20.
    Wang Q. Effects of bronchoalveolar lavage with dexamethasone combined with Tanreqing Injection on cytokines in serum and broncho-alveolar lavage fluid in patients with acute lung injury. Mod J Integr Tradit Chin West Med (Chin) 2017;26:2093–2096.Google Scholar
  21. 21.
    Zhang ZL, Lin H, Wang GH, et al. Study on the protective effect of heat-clearing and phlegm-resolving method on acute lung injury patients with syndrome of phlegm-heat accumulation in Lung. Lishizhen Med Mater Med Res (Chin) 2014;25:2444–2446.Google Scholar
  22. 22.
    Ouyang T, Ouyang YP, Wei QJ. The affects on the Xuebijing Injection against respiratory function and early inflammatory response in patients with ALI. Clin J Chin Med (Chin) 2012;4:6–8.Google Scholar
  23. 23.
    Bai SX. Clinical observation of Xuebijing in patients with severe pneumonia complicated with ARDS. Shandong Med J (Chin) 2014;54:61–62.Google Scholar
  24. 24.
    Wang XD, Li M, Zhang C, et al. Effects of Xuebijing in patients with acute respiratory distress syndrome. J Xuzhou Med Univ (Chin) 2007;27:732–735.Google Scholar
  25. 25.
    Wu X, Li WF, Liu XF. Effects of Shenfu Injection on extravascular lung water and oxygenation in patients with ARDS. J Emerg Tradit Chin Med (Chin) 2008;17:1702–1704.Google Scholar
  26. 26.
    Wang LC, Liu XF, He C, et al. Study of Shenfu Injection on blood flow volume of lungs and breathing mechanics in ARDS. J Emerg Tradit Chin Med (Chin) 2010;19:774–775,792.Google Scholar
  27. 27.
    Peng ZY, Peng HQ, Lin HW, et al. Effect on acute lung injury in patients with sepsis by supplementing qi nourishing yin and promoting blood flow. J Liaoning Univ Tradit Chin Med (Chin) 2014;16:168–170.Google Scholar
  28. 28.
    Liu XF. Clinical effects and ICAM-1, ET-1 and NO levels of Shengmai Injection in treatment of acute lung injury. Mod J Integr Tradit Chin West Med (Chin) 2017;26:2784–2786.Google Scholar
  29. 29.
    Shi CH, Zhang JB, Xu GB, et al. Effect and safety of Danshen Injection in the treatment of patients with acute lung injury. Chin J Clin Pharmacol (Chin) 2013;29:501–502.Google Scholar
  30. 30.
    Qian FH, Qian YM, Zhu L, et al. The clinical effect of Reduning Injection on acute lung injury. Chin J Prim Med Pharm (Chin) 2010;17:1318–1319.Google Scholar
  31. 31.
    Liu CP, Hu P, Li CH, et al. Therapeutic value of aescine in traumatic acute lung injury. J Trauma Surg (Chin) 2013;15:497–499.Google Scholar
  32. 32.
    Guo XY, Chen RY, Zhang Y. Effect of Erigeron Breviscapus Injection on inflammatory factors and clotting mechanism in ARDS patients. J Emerg Tradit Chin Med (Chin) 2015;24:854–856.Google Scholar
  33. 33.
    Meng L, Chen HL, Lin HW. Effects of Rhodiola Wallichiana Injection on clinical efficacy and the concentration of VEGF-A of EBC in patients with ALI/ARDS. J Clin Emerg (Chin) 2018;19:97–101.Google Scholar
  34. 34.
    Zheng XY, ed. Guiding principle of clinical research on new drugs of traditional Chinse medicine. Beijing: Medic-Pharmaceutical Sciences and Technology Publishing House;2002:54–60.Google Scholar
  35. 35.
    The State Administration of Traditional Chinese Medicine. Criteria for the diagnosis and therapeutic effect of Chinese medicine on dyspnea. J Liaoning Univ Tradit Chin Med (Chin) 2015;17:67.Google Scholar
  36. 36.
    The Ministry of health, the State Food and Drug Administration and the State Administration of traditional Chinese Medicine. Notice on further strengthening the administration and administration of traditional Chinese medicine injections. People’s Republic of China State Health and Family Planning Commission Bulletin;2009:64-65.Google Scholar
  37. 37.
    Han W, He E, Cao J. Application of traditional Chinese medicine injections using traditional Chinese medicine theory. Chin J Chin Mater Med (Chin) 2012;37:2498–2500.Google Scholar
  38. 38.
    Matthay MA, Ware LB, Zimmerman GA. The acute respiratory distress syndrome. J Clin Invest 2012;122:2731–2740.PubMedPubMedCentralCrossRefGoogle Scholar
  39. 39.
    Chen JW, Lin HX, Li SW. A clinical study on ulinastatin combined with Salvas Miltiorrhiza in adjuvant treatment of acute lung injury. Int Med Health Guid News (Chin) 2013;19:322–324.Google Scholar
  40. 40.
    Luo P, Zhou ZX. Protective effects of Xuebijing on the acute lung injury in rats. Chin J Appl Physiol (Chin) 2017;33:132–135.Google Scholar
  41. 41.
    Tang LP, Xiao W, Li YF, et al. Anti-inflammatory effects of Reduning Injection on lipopolysaccharide-induced acute lung injury of rats. Chin J Integr Med 2014;20:591–599.PubMedCrossRefPubMedCentralGoogle Scholar
  42. 42.
    Wang P, Zhao HD. Study of Xuebijing on the treatment mechanism of acute lung injury. Chin J Crit Care Med (Chin) 2010;30:79–81.Google Scholar
  43. 43.
    Zhuang XF, Yu SL, Fan ML, et al. Advances on mechanism research of traditional Chinese prescription for the treatment of acute lung injury. Chin J Exp Tradit Med Form (Chin) 2012;18:326–331.Google Scholar
  44. 44.
    de Haro C, Martin-Loeches I, Torrents E, et al. Acute respiratory distress syndrome: prevention and early recognition. Ann Intensive Care 2013;3:11.PubMedPubMedCentralCrossRefGoogle Scholar
  45. 45.
    Bian ZX, Tian HY, Gao L, et al. Improving reporting of adverse events and adverse drug reactions following injections of Chinese materia medica. J Evid Based Med (Chin) 2010;3:5–10.CrossRefGoogle Scholar
  46. 46.
    State Food and Drug Administration. Notice on the revaluation of safety of traditional Chinese medicine injections. Adv Drug React J (Chin) 2009;11:353–360.Google Scholar
  47. 47.
    Kang RX, You RL, Wang L, et al. In vitro experiment of allergic reactions induced by traditional Chinese medicine injections. Chin J Chin Mater Med (Chin) 2015;40:2503–2507.Google Scholar
  48. 48.
    Li Y, Zhang J. Improvement and enhancement of traditional Chinese medicine injections. Chin J Chin Mater Med (Chin) 2011;36:1905–909.Google Scholar
  49. 49.
    Zhang M. Advance of polysorbate 80 for injection accessories. Chin J Chin Mater Med (Chin) 2011;36:1910–191.Google Scholar
  50. 50.
    Xiong XJ, Wang J, He QY. Application status and safety counter measures of traditional Chinese medicine injections. J Chin Integr Med (Chin) 2010;8:307–311.CrossRefGoogle Scholar
  51. 51.
    Ji K, Chen J, Li M, et al. Comments on serious anaphylaxis caused by nine Chinese herbal injections used to treat common colds and upper respiratory tract infections. Regul Toxicol Pharmacol (Chin) 2009;55:134–138.CrossRefGoogle Scholar
  52. 52.
    Chen F, Liu Z, Safety evaluation of traditional Chinese medicine injections and study of related key technology. Chin J Chin Mater Med (Chin) 2009;34:1052–1054.Google Scholar
  53. 53.
    Sine CR, Belenkiy SM, Buel AR, et al. Acute respiratory distress syndrome in burn patients: a comparison of the Berlin and American-European definitions. J Burn Care Res 2016;37:e461–e469.PubMedCrossRefPubMedCentralGoogle Scholar
  54. 54.
    Villar J, Perez-Mendez L, Lopez J, et al. An early PEEP/FiO2 trial identifies different degrees of lung injury in patients with acute respiratory distress syndrome. Am J Respir Crit Care Med 2007;176:795–804.PubMedCrossRefPubMedCentralGoogle Scholar
  55. 55.
    Ferguson ND, Meade MO, Hallett DC, et al. High values of the pulmonary artery wedge pressure in patients with acute lung injury and acute respiratory distress syndrome. Intensive Care Med 2002;28:1073–1077.PubMedCrossRefPubMedCentralGoogle Scholar
  56. 56.
    Wheeler AP, Bernard GR, Thompson BT, et al. Pulmonary-artery versus central venous catheter to guide treatment of acute lung injury. N Engl J Med 2006;354:2213–2224.PubMedCrossRefPubMedCentralGoogle Scholar
  57. 57.
    Hopewel S, Clarke M, Moher D, et al. CONSORT for reporting randomized controlled trials in journal and conference abstracts: explanation and elaboration. PLoS Med 2008;5:48–56.CrossRefGoogle Scholar
  58. 58.
    Pildal J, Hróbjartsson A, Jorgense KJ, et al. Impact of allocation concealment on conclusions drawn from meta-analyses of randomized trials. Int J Epidemiol 2007;36:847–857.PubMedCrossRefPubMedCentralGoogle Scholar

Copyright information

© The Chinese Journal of Integrated Traditional and Western Medicine Press and Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  • Yuan-bin Chen
    • 1
    • 2
    • 3
  • Qiao Liu
    • 4
  • Han Xie
    • 2
    • 3
  • Shuo-miao Yin
    • 1
  • Lei Wu
    • 2
    • 3
  • Xu-hua Yu
    • 2
    • 3
  • Long Fan
    • 2
    • 3
  • Lin Lin
    • 2
    • 3
    • 5
    Email author
  1. 1.Second Clinical College of Guangzhou University of Chinese MedicineGuangzhouChina
  2. 2.Department of Respiratory MedicineThe Second Affiliated Hospital of Guangzhou University of Chinese MedicineGuangzhouChina
  3. 3.Department of Respiratory MedicineGuangdong Provincial Hospital of Chinese MedicineGuangzhouChina
  4. 4.Department of Internal MedicineHeyuan Hospital of Traditional Chinese Medicine, HeyuanGuangdong ProvinceChina
  5. 5.ZHOU Zhong-ying Famous Doctors’ Workshop of Guangdong Provincial Hospital of Chinese MedicineGuangzhouChina

Personalised recommendations